Found 30 matching trials
International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
PHASE3This is an international phase III trial, with a Bayesian design, incorpora...
Location
Los Angeles County-USC Medical Center
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
PHASE2The purpose of this study is to find out whether combining a shorter than s...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator
N/AThe incidence rate of colorectal cancer is third in male tumors and second ...
Status
Enrolling By Invitation
Location
Sun Yat-sen University Cancer Center
Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas
EARLY_PHASE1This is an open-label, dose-finding study of XRD-0394 in subjects with newl...
Location
NYU Langone Health
Window of Opportunity in Preserving Laryngeal Function Trial
PHASE2This trial will study the safety and tolerability and disease survival rate...
Location
UPMC Hillman Cancer
Comparing Hypofractionated Radiotherapy Boost to Conventionally Fractionated
NAThe main purpose of study is to compare the effectiveness of Hypofractionat...
Location
Lower-Silesian Oncology Centre
PSMA PET Response Guided SabR in High Risk Pca
PHASE1Sequential cohort evaluation of ideal timing of imaging and treatment spaci...
Location
University of Texas Southwestern Medical Center
A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer
NAStereotactic body radiotherapy (SBRT) has emerged as an effective and safe ...
Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma
PHASE2The purpose of the study is to utilize radiomic images to precisely locate ...
Location
Moffitt Cancer Center
PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer
PHASE2PRO-BOOST-LC is a prospective, multicenter, randomized phase II/III clinica...
Location
Affidea Nu-Med, Center of Oncological Diagnostics and Therapy